- Latest Deal Type
- Financing Rounds
LactoStop General Information
Developer of anti-lactose intolerant medicine intended to enable people with a lactose intolerance to enjoy milk products. The company's anti-lactose intolerant medicine replaces the body-specific lactase lacking in lactose-intolerant individuals, enabling patients to avail high-quality natural products, food supplements and medical products.
Corporate Backed or Acquired
- Am Haag 14
- 82166 Grafelfing
+49 089 000000000
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
LactoStop Valuation & Funding
LactoStop Executive Team (1)
|Name||Title||Board Seat||Contact Info|
|Clemens Fischer Ph.D||Chief Executive Officer|
LactoStop Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|